Hyperuricemia

154 clinical trials · Condition

Record	Firm	Date
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients (NCT00186940)	St. Jude Children's Research Hospital	2005-03-01
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome (NCT00230178)	Sanofi	2004-04-01
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy (NCT00230217)	Sanofi	2004-03-01
Treatment of Hyperuricemia in Patients With Heart Failure (NCT00422318)	Tottori University Hospital	2004-01-01
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma (NCT00631579)	Sanofi	2003-04-01
Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma (NCT00664144)	Sanofi	2002-07-01
Magnetic Resonance Imaging in Subjects With Gouty Tophi (NCT00174954)	Takeda	2002-03-01
Allopurinol in Chronic Heart Failure (NCT00997542)	National Heart and Lung Institute
Phase II Exploratory Clinical Study of KUX-1151 (NCT02190786)	Kissei Pharmaceutical Co., Ltd.

Every clearance here is in the API, with alerts when new ones post.